Physician profile
Jonathan E Lippman
NPI 1497307656
$612.46
in general payments reported to CMS, 2019-2025
17 companies · $22.02 in 2025
The $22.02 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $129 · 2023: $153 · 2024: $185 · 2025: $22.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $80.56 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Genentech USA, INC. | $69.76 | 2024 | Xolair |
| Nalu Medical, INC. | $69.04 | 2023 | Nalu Neurostimulation System |
| Lilly USA, LLC | $52.23 | 2023 | Emgality |
| Averitas Pharma INC. | $49.63 | 2024 | Qutenza |
| Medtronic, INC. | $42.64 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $41.05 | 2021 | |
| Collegium Pharmaceutical, INC. | $28.80 | 2023-2024 | Xtampza, Belbuca |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.39 | 2022 | |
| Stryker Corporation | $22.02 | 2025 | Flowtriever |
| Grt US Holding, INC. | $21.13 | 2022 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.38 | 2022 | |
| Pfizer INC. | $18.76 | 2021 | |
| Allergan, INC. | $18.45 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.27 | 2023 | Relistor |
| Abbvie INC. | $16.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lippman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.